About this journal

Aims and scope

Published by Elsevier from 2022.

Structural Heart: The Journal of the Heart Team is an international journal publishing research on structural heart disorders and related cardiovascular diseases.

Structural Heart is an official journal of the Cardiovascular Research Foundation.

Structural heart disorders have become the most rapidly growing aspect of cardiovascular practice. The explosive growth of structural heart disease interventions, fuelled by new, more accurate non-invasive diagnostic assessment and breakthrough interventional and surgical therapy, has generated abundant research data. Presentations on structural heart disorders now occupy a large segment of national cardiovascular meetings. These clinical advances benefit from team decision-making and collaboration among various professional disciplines involved in the care of these patients.
There is a growing need for new types of information to be disseminated to all members of the heart team, and Structural Heart is committed to being the conduit for this novel, and much-needed information.

Structural Heart focuses on diseases of the heart valves, myocardium, pericardium, and great vessels as well as congenital heart disease. Specific areas of interest include:

  • diagnostic techniques
  • percutaneous interventional procedures
  • cardiovascular surgery
  • drug treatment
  • findings from the laboratory
  • clinical trials

Structural Heart accepts the following types of articles: original research, symposia, clinical reviews and updates, editorials, letters, opinion pieces and commentary. The journal also publishes consensus documents and white papers with recommendations on current topics in cardiovascular disease.

Structural Heart operates a single blind peer review policy.

Sorry, there are currently no metrics available for this journal.

Abstracting and indexing

Structural Heart is included in the following services:

Scopus

EMBASE

Cardiovascular Research Foundation and our publisher Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Cardiovascular Research Foundation and our publisher Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Cardiovascular Research Foundation and our publisher Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Cardiovascular Research Foundation and our publisher Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days
HRB Open Research is a platform for HRB-funded researchers to rapidly publish their research outputs in an open and accessible way.